Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon Sim Yap

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
The Analyst|May 21, 2014
An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cellsMajid Ebrahimi Warkiani, Bee Luan Khoo, Daniel Shao-Weng Tan, et al.
Breast Cancer Research and Treatment|May 24, 2019
Assessment of PARP4 as a candidate breast cancer susceptibility geneAldo Prawira, Prabhakaran Munusamy, Jimin Yuan, et al.
Future Science OA|November 15, 2017
A preliminary study for the assessment of PD-L1 and PD-L2 on circulating tumor cells by microfluidic-based chipcytometryJinkai Teo, Anja Mirenska, Meihui Tan, et al.
NPJ Breast Cancer|August 1, 2018
Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancersYoon-Sim Yap, Angad P Singh, John H C Lim, et al.
Cancer Science|July 4, 2020
Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancerYoon-Sim Yap, Joanne Chiu, Yoshinori Ito, et al.
Genome Research|November 22, 2022
Marker-free characterization of full-length transcriptomes of single live circulating tumor cellsSarita Poonia, Anurag Goel, Smriti Chawla, et al.
Cancer Research|August 5, 2017
Identification of Novel Breast Cancer Risk LociClaire Hian Tzer Chan, Prabhakaran Munusamy, Sau Yeen Loke, et al.
British Journal of Clinical Pharmacology|January 23, 2016
Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patientsJoanne Siok Liu Lim, Natalia Sutiman, Thomas E Muerdter, et al.
British Journal of Cancer|February 5, 2019
Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse preventionBee Luan Khoo, Gianluca Grenci, Joey Sze Yun Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2- Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7Aleix Prat, Nadia Solovieff, Fabrice André, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
The Analyst|May 21, 2014
An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cellsMajid Ebrahimi Warkiani, Bee Luan Khoo, Daniel Shao-Weng Tan, et al.
Breast Cancer Research and Treatment|May 24, 2019
Assessment of PARP4 as a candidate breast cancer susceptibility geneAldo Prawira, Prabhakaran Munusamy, Jimin Yuan, et al.
Future Science OA|November 15, 2017
A preliminary study for the assessment of PD-L1 and PD-L2 on circulating tumor cells by microfluidic-based chipcytometryJinkai Teo, Anja Mirenska, Meihui Tan, et al.
NPJ Breast Cancer|August 1, 2018
Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancersYoon-Sim Yap, Angad P Singh, John H C Lim, et al.
Cancer Science|July 4, 2020
Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancerYoon-Sim Yap, Joanne Chiu, Yoshinori Ito, et al.
Genome Research|November 22, 2022
Marker-free characterization of full-length transcriptomes of single live circulating tumor cellsSarita Poonia, Anurag Goel, Smriti Chawla, et al.
Cancer Research|August 5, 2017
Identification of Novel Breast Cancer Risk LociClaire Hian Tzer Chan, Prabhakaran Munusamy, Sau Yeen Loke, et al.
British Journal of Clinical Pharmacology|January 23, 2016
Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patientsJoanne Siok Liu Lim, Natalia Sutiman, Thomas E Muerdter, et al.
British Journal of Cancer|February 5, 2019
Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse preventionBee Luan Khoo, Gianluca Grenci, Joey Sze Yun Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2- Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7Aleix Prat, Nadia Solovieff, Fabrice André, et al.
Pageof 10